• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • News
  • Lifestyle
  • Wellness
  • Cuisine
  • Product Reviews
  • Subscribe
Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Emerald Media News Subscription
  • Print Magazines
  • 100+ Minority-Owned Companies to Support
  • No Pipe, No Problem
  • Blunt vs. Joint
  • The Cost of Cannabis in Each State
  • Calculating Your Edibles Dosage
  • Flintts Mouthwatering Mints

FDA Releases New Guidelines for Cannabis Research

July 25, 2020 by Rita Thompson Leave a Comment

CBD has become one of the biggest trends sweeping the nation. While the cannabinoid was deemed federally legal by the 2018 Farm Bill, however, the Food and Drug Administration (FDA) has still approved only one CBD product — a prescription drug treating two rare, severe forms of epilepsy. 

Thus, as CBD products continue to pop up virtually everywhere from CVS to Ulta Beauty, industry leaders and consumers alike are concerned over the lack of FDA approval. As a result, customers and retailers are pushing for more support. 

FDA Draft Guidance

On Tuesday, July 21st, the FDA issued a draft guidance establishing a set of guidelines for studying cannabis in the U.S. 

The guidance — which includes a cannabis testing program — specifically draws concern over inaccurate marketing for CBD products accessed by retailers and dispensaries, as well as a lack of data in regards to food products and dietary supplements. 

The program, deemed the Cannabis Quality Assurance (CannaQAP) program, would help laboratories accurately measure chemical compounds, and increase the accuracy of distinguishing between plants and labeling products. 

“When you walk into a store or dispensary and see a label that says 10% CBD, you want to know that you can trust that number,” NIST research chemist, Brett Wilson, explained to Marijuana Moment. 

“This change gives sponsors and investigators of clinical studies new options that do not involve the [National Institute on Drug Abuse Drug Supply Program],” the FDA wrote.

Just CBD?

The CannaQAP will focus on hemp-derived oils like CBD, but officials said it’s possible they will expand the program to test cannabis flower, concentrates and edibles. 

“A range of stakeholders have expressed interest in development of drugs that contain cannabis and compounds found in cannabis. Recent legislative changes have also opened new opportunities for cannabis clinical research,” FDA Principal Deputy Commissioner Amy Abernethy said in a statement Tuesday. “As that body of research progresses and grows, the FDA is working to support drug development in this area.”

Is it Enough?

In order to fully reap the benefits of cannabis, access needs be granted not only to consumers, but to scientists to conduct research on it’s benefits, or lack thereof. 

However, research is virtually impossible as the plant remains an illegal, Schedule I drug under federal law. 

Thus, many advocates find the increase of CBD research to fall short of the bigger picture. 

Paul Armentano, Deputy Director of the National Organization for the Reform of Marijuana Laws (NORML), told The Hill the new guidance is not enough.

“As best I can tell, these newly proposed guidelines provide little if anything in the way of substantive new guidance that will significantly address the existing untenable situation,” he said.

Until cannabis becomes federally legal and consequently available for research, we will continue to lack vital information about the plant itself, and its potential to heal a nation. 

Filed Under: Current, Lifestyle Tagged With: cannabis, cannabis research, CBD, cbd research, farm bill, federal illegality, research

Reader Interactions

Leave a Reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Advertise Here

Categories

Sustainability

seaweed naturals

SeaWeed Naturals Combines the Power of Seaweed with Cannabis to Further Ocean Restoration

April 3, 2022 By Maggie Horton

fungi climate change

Research Finds Fungi Help Ease Climate Change and Benefit the Environment

March 30, 2022 By Julia Meyer

climate crisis and the pandemic

“We Can Act:” What Bending the COVID-19 Curve Teaches Us About the Climate Crisis

April 21, 2020 By Melissa Hutsell

Footer

  • Subscribe
  • About
  • Contact
  • Privacy
  • Press

Recent

  • Up in Smoke: An Interview with Smoke Proper, the Trailblazing Cannabis Accessory Brand
  • Priscilla Vilchis and Lil Kim Launch Aphrodisiak: A Cannabis Brand Focused on Sensuality, Social Justice, and Inclusivity
  • First Latina CEO of a Cannabis Company Partners with Music Industry Trailblazer Lil Kim to Launch Aphrodisiak Brand
  • Aphrodisiak: The New Female-Led Cannabis Brand Empowering Women and Promoting Inclusivity
  • Las Vegas Welcomes Aphrodisiak

Search

Copyright © 2023 · The Emerald™ · News & Lifestyle Magazine

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Cannabis News and Culture Magazine
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.